Evidence map›Paper›PMID 24488418›Full record

SynthesisThe Journal of rheumatology2014

Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Gulen Hatemi, Peter A Merkel, Vedat Hamuryudan, Maarten Boers, Haner Direskeneli, Sibel Z Aydin, Hasan Yazici

4 registry-linked trialsOpen access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in The Journal of rheumatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03771768 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Active Control,Randomized,Double- Blinded Clinical Trial of BD

TypeinterventionalSponsorCairo UniversityRan2019 to 2019Enrolled38ConditionsAutoimmune, Behcet SyndromeArmsDiode laser 980nm&100 mWatt, Triamcinolone Acetonide
NCT03803462 unknown statusnot on this mapstarted 2017, after this paper: background citation

Development and Preliminary Validation of the Behçet's Disease Overall Damage Index

TypeobservationalSponsorUniversity of CagliariRan2017 to 2019Enrolled210ConditionsBehçet Disease, Behcet's Disease AggravatedArmsBehçet's disease Overall Damage Index (BODI)
NCT03837236 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease

TypeinterventionalSponsorGazi UniversityRan2019 to 2019Enrolled82ConditionsBehçet DiseaseArmsStudy group
NCT06084624 phase1 / phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease: A Randomized Clinical Trial

TypeinterventionalSponsorCairo UniversityRan2023 to 2025Enrolled40ConditionsOral Ulceration Due to Behçet's DiseaseArmsRebamipide mouthwash, Betamethasone mouthwash
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Interventions for the management of oral ulcers in Behçet's disease.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Can the mucosal attacks of Behçet's disease be predicted?Archives of dermatological research · 2024
    Article
  10. Article
  11. Review
  12. Behçet syndrome.Nature reviews. Disease primers · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Behçet syndrome: a contemporary view.Nature reviews. Rheumatology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Gulen HatemiFrom the Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey; Division of Rheumatology and Department of Epidemiology, University of Pennsylvania, Philadelphia, PA, USA; Department of Clinical Epidemiology, VU University Medical Center, Amsterdam, The Netherlands; Department of Rheumatology, Marmara University School of Medicine, Istanbul; Department of Rheumatology, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
Peter A Merkel
Vedat Hamuryudan
Maarten Boers
Haner Direskeneli
Sibel Z Aydin
Hasan Yazici
Amsterdam UMC Location VUmc · NLIstanbul Medeniyet University · TRIstanbul University · TRMarmara University · TRUniversity of Pennsylvania · US

Funding

VCRC-VF FellowshipU54AR057319 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MERKEL, PETER A · 2009 to 2020
$12.5M
NCRR NIH HHS U54 RR01949703NIAMS NIH HHS U54 AR057319NIAMS NIH HHS U54AR057319
6 · The paper itself

Abstract

Behçet syndrome (BS) is a multisystem vasculitis that is most active during young adulthood, causing serious disability and significant impairment in quality of life. Differences in the disease course, severity, and organ involvement between patients, depending on the age at presentation and sex, makes it impossible to determine a single management strategy. The diversity and variability in the outcome measures used in clinical trials in BS makes it difficult to compare the results or inform physicians about the best management strategy for individual patients. There is a large unmet need to determine or develop validated outcome measures for use in clinical trials in BS that are acceptable to researchers and regulatory agencies. We conducted a systematic review to describe the outcomes and outcome measures that have been used in clinical trials in BS. This review revealed the diversity and variability in the outcomes and outcome measures and the lack of standard definitions for most outcomes and rarity of validated outcome tools for disease assessment in BS. This systematic literature review will identify domains and candidate instruments for use in a Delphi exercise, the next step in the development of a core set of outcome measures that are properly validated and widely accepted by the collaboration of researchers from many different regions of the world and from different specialties, including rheumatology, ophthalmology, dermatology, gastroenterology, and neurology.

Indexed as

Clinical Trials as TopicOutcome Assessment, Health CareBehcet SyndromeDisease ProgressionHumansQuality of LifeASSESSMENTBEHÇET SYNDROMEOUTCOMESSYSTEMATIC REVIEW

Identifiers

PMID24488418
PMCPMC4508275
OpenAlexW2115103969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.